MyFinsight
Home
Blog
About
Contact
Download
Download image
Accounts receivable, net
of allowance for...
$9,313K
Cash and cash
equivalents
$26,061K
Other current assets
and prepaid...
$31,330K
Inventory, net
$11,411K
Intangible assets, net of
accumulated amortization of...
$3,807K
Operating lease
right-of-use assets, net of...
$18,748K
Other non-current
assets
$94K
Property, plant and
equipment, net of...
$28,152K
Restricted cash
$1,717K
Total current assets
$78,115K
Total assets
$130,633K
Accumulated other
comprehensive loss
-$10,612K
Accumulated deficit
-$1,171,911K
Total liabilities and
stockholders' equity
$130,633K
Total stockholders'
equity
-$70,958K
Additional paid in capital
$1,109,409K
Common stock - ordinary
shares par value 0.001,...
$2,156K
Total liabilities
$201,591K
Deferred revenue,
non-current
$101,419K
Borrowings, non-current
$25,675K
Operating lease
liabilities, non-current
$18,491K
Other liabilities,
non-current
$4,493K
Total current
liabilities
$51,513K
Accounts payable
$9,418K
Deferred revenue,
current
$10,700K
Operating lease
liabilities, current
$4,514K
Accrued expenses and
other current...
$24,526K
Restructuring provision
$2,355K
Back
Back
Balance Sheet
source: myfinsight.com
Adaptimmune Therapeutics PLC (ADAP)
Adaptimmune Therapeutics PLC (ADAP)